Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Temgesic 200microgram sublingual tablets
0407020B0BBAAAB
|
Temgesic | Buprenorphine | Central Nervous System | 1,558 |
|
Temgesic 400microgram sublingual tablets
0407020B0BBADAD
|
Temgesic | Buprenorphine | Central Nervous System | 906 |
|
Temgesic 300micrograms/1ml solution for injection ampoules
0407020B0BBABAA
|
Temgesic | Buprenorphine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.